Patents by Inventor Kim C. O'Connor

Kim C. O'Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF IMPROVING THE IN VIVO SURVIVAL OF MESENCHYMAL STEM CELLS
    Publication number: 20220154146
    Abstract: Methods of improving the in vivo survival of mesencymal stem cells are described. The method comprising the steps of: a) selecting, from a heterogeneous group of MSCs, MSCs having high expression of NG2; b) expanding the MSCs selected in step a); c) attaching the MSCs expanded in step b) to a scaffold; and d) implanting the scaffold with the MSCs in a mammal.
    Type: Application
    Filed: March 18, 2020
    Publication date: May 19, 2022
    Inventors: Kim C. O'CONNOR, Sean D. MADSEN, Bruce A. BUNNELL
  • Cell-surface marker of early MSC aging
    Patent number: 10458985
    Abstract: This invention relates to a cell-surface marker for identifying MSC that are aging. This invention also relates to a method of screening MSCs of low proliferation potential and trilineage potential by removing CD264+ MSCs from the population.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: October 29, 2019
    Assignee: The Administrators of the Tulane Educational Fund
    Inventor: Kim C. O'Connor
  • CELL-SURFACE MARKER OF EARLY MSC AGING
    Publication number: 20170016898
    Abstract: This invention relates to a cell-surface marker for identifying MSC that are aging. This invention also relates to a method of screening MSCs of low proliferation potential and trilineage potential by removing CD264+ MSCs from the population.
    Type: Application
    Filed: April 10, 2015
    Publication date: January 19, 2017
    Applicant: The Administrators of the Tulane Educational Fund
    Inventor: Kim C. O'Connor
  • Three dimensional optic tissue culture and process
    Patent number: 5962324
    Abstract: A process for artificially producing three-dimensional optic tissue has been developed. The optic cells are cultured in a bioreactor at low shear conditions. The tissue forms as normal, functional tissue grows with tissue organization and extracellular matrix formation.
    Type: Grant
    Filed: May 13, 1994
    Date of Patent: October 5, 1999
    Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space Adminstration
    Inventors: Kim C. O'Connor, Glenn F. Spaulding, Thomas J. Goodwin, Laurie A. Aten, Karen M. Francis, Delmar R. Caldwell, Tacey L. Prewett, Wendy S. Fitzgerald
  • Recombinant protein production and insect cell culture and process
    Patent number: 5637477
    Abstract: A process has been developed for recombinant production of selected polypeptides using transformed insect cells cultured in a horizontally rotating culture vessel modulated to create low shear conditions. A metabolically transformed insect cell line is produced using the culture procedure regardless of genetic transformation. The recombinant polypeptide can be produced by an alternative process using virully infected or stably transformed insect cells containing a gene encoding the described polypeptide. The insect cells can also be a host for viral production.
    Type: Grant
    Filed: August 16, 1994
    Date of Patent: June 10, 1997
    Assignee: The United States of America as respresented by the Administrator of the National Aeronautics and Space Administration
    Inventors: Glenn F. Spaulding, Thomas J. Goodwin, Kim C. O'Connor, Karen M. Francis, Angela D. Andrews, Tacey L. Prewett